Literature DB >> 32004963

Serum concentrations of persistent organic pollutants and the metabolic syndrome in Akwesasne Mohawks, a Native American community.

Zafar Aminov1, David O Carpenter2.   

Abstract

The metabolic syndrome (MetS) is a group of diseases that tend to occur together, including diabetes, hypertension, central obesity, cardiovascular disease and hyperlipidemia. Exposure to persistent organic pollutants (POPs) such as polychlorinated biphenyls (PCBs) and organochlorine pesticides (OCPs) has been associated with increased risk of development of several of the components of the MetS. The goal of this study is to determine whether the associations with POPs are identical for each of the components and for the MetS. The subject population was 601 Native Americans (Akwesasne Mohawks) ages 18 to 84 who answered a questionnaire, were measured for height and weight and provided blood samples for clinical chemistries (serum lipids and fasting glucose) and analysis of 101 PCB congeners and three OCPs [dichlorodiphenyldichloroethylene (DDE), hexachlorobenzene (HCB) and mirex]. Associations between concentrations of total PCBs and pesticides, as well as various PCB congener groups with each of the different components of the MetS were determine so as to ask whether there were similar risk factors for all components of the MetS. After adjustment for other contaminants, diabetes and hypertension were strongly associated with lower chlorinated and mono-ortho PCBs, but not other PCB groups or pesticides. Obesity was most closely associated with highly chlorinated PCBs and was negatively associated with mirex. High serum lipids were most strongly associated with higher chlorinated PCBs and PCBs with multiple ortho-substituted chlorines, as well as total pesticides, DDE and HCB. Cardiovascular disease was not closely associated with levels of any of the measured POPs. While exposure to POPs is associated with increased risk of most of the various diseases comprising the MetS, the specific contaminants associated with risk of the component diseases are not the same.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Hyperlipidemia; Hypertension; Native Americans; Obesity

Mesh:

Substances:

Year:  2020        PMID: 32004963     DOI: 10.1016/j.envpol.2020.114004

Source DB:  PubMed          Journal:  Environ Pollut        ISSN: 0269-7491            Impact factor:   8.071


  5 in total

Review 1.  An evidence map of polychlorinated biphenyl exposure and health outcome studies among residents of the Akwesasne Mohawk Nation.

Authors:  Chelsea A Weitekamp; Rachel M Shaffer; Catheryne Chiang; Geniece M Lehmann; Krista Christensen
Journal:  Chemosphere       Date:  2022-06-25       Impact factor: 8.943

Review 2.  Biomarkers of metabolic disorders and neurobehavioral diseases in a PCB- exposed population: What we learned and the implications for future research.

Authors:  Jyothirmai J Simhadri; Christopher A Loffredo; Tomas Trnovec; Lubica Palkovicova Murinova; Gail Nunlee-Bland; Janna G Koppe; Greet Schoeters; Siddhartha Sankar Jana; Somiranjan Ghosh
Journal:  Environ Res       Date:  2020-09-13       Impact factor: 6.498

3.  The associations between p,p'-DDE levels and plasma levels of lipoproteins and their subclasses in an elderly population determined by analysis of lipoprotein content.

Authors:  Juliann Jugan; P Monica Lind; Samira Salihovic; Jordan Stubleski; Anna Kärrman; Lars Lind; Michele A La Merrill
Journal:  Lipids Health Dis       Date:  2020-12-07       Impact factor: 3.876

4.  Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma.

Authors:  Sarah Allegra; Soraya Puglisi; Chiara Borin; Francesco Chiara; Vittoria Basile; Anna Calabrese; Giuseppe Reimondo; Silvia De Francia
Journal:  Biomedicines       Date:  2022-08-03

5.  PCB118 Induces Inflammation of Islet Beta Cells via Activating ROS-NLRP3 Inflammasome Signaling.

Authors:  Chunxia Jiang; Yuping Wang; Man Guo; Yang Long; Jiao Chen; Fang Fan; Shi Tang; Yong Xu
Journal:  Biomed Res Int       Date:  2021-05-17       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.